Grants

Filtering by: “MPSI”

Aug
9
to Oct 17

2022 MPS I PILOT GRANT PROGRAM

2022 MPS I PILOT GRANT PROGRAM

Overview

One-year grants up to $150,000 (direct costs) will be available to develop novel treatments for MPS I. The proposed therapeutic strategies should address the unmet needs of CNS manifestations of MPS I in patients with the severe and attenuated forms of the disease. Approaches that also address the somatic manifestations of the disease including the eye, bone, connective-tissue, and heart, which not effectively treated with enzyme replacement therapy or bone marrow transplantation are welcome.

The applicant must have a proven track record in the development of novel therapeutics that progress toward clinical applications. The applicant must demonstrate utility of the proposed therapeutic platform in MPS I animal models during the course of the grant. A second year of funding is possible but should not be incorporated into the initial application.

Eligibility

All individuals holding a faculty‐level appointment at an academic institution or a senior scientific position at a non-profit institution or foundation are eligible to respond to this RFA.

Full Application (by invitation only) are Due Monday, October 17, 2022 by 8 PM EST.

To Apply:

Step 1 - Please review the "Full Application Instructions and Review Procedure" section of the 2022 MPS I Pilot Grant Program RFA Guidelines.


Step 2 - Download and complete the below forms:

Step 3 - Complete the Application Form on Submittable.


For any scientific inquiries regarding this grant please email Cara M. Weismann PhD.

For any administrative inquiries regarding this grant please email Samantha Charleston.

View Event →